MarketCap
Facebook
X
Telegram
Surmodics Financial Ratios 2024-2008 | SRDX
Brief overview of Surmodics's market valuation
The review covers five available annual periods spanning 2016 to 2021.
Key multiples at the end of the period are P/E 145.8x (median 145.8x), EV/EBITDA 189.45x (median 43.55x), P/S 4.39x (median 5.07x). Ratios sit near their own comparison base, with an average deviation of 0% from five-year medians.
At the current P/E, inverse earnings yield is 0.7%, a useful bridge between price and business earnings.
The latest available business-quality ratios are ROE -9.7%, ROA -6.5%, ROCE -4.7%. Current return ratios are negative, materially weakening the fundamental profile.
PEG of 0.63x shows valuation is not outpacing embedded growth. The conclusion depends on earnings durability.
A longer cycle, from 113.9 days to 168.8 days, indicates slower release of cash from operations.
Valuation takeaway
Surmodics trades near its familiar ratio range. A new earnings or profitability trend is needed to change the view.
Annual Financial Ratios Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-48.0 | -312.7 | -18.6 | 145.8 | 629.3 | 61.6 | 586.0 | -254.4 | 139.9 | 91.6 | 90.7 | 99.2 | 103.4 | 58.7 | - | - | - |
P/S |
4.4 | 3.6 | 5.1 | 5.9 | 7.5 | 4.7 | 33.3 | 23.3 | 18.1 | 14.7 | 23.1 | 25.9 | 31.7 | 4.7 | - | - | - |
EPS |
-0.8 | -0.1 | -2.0 | 0.3 | 0.1 | 0.6 | 0.1 | -0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | -0.4 | 2.1 | - |
EV (Enterprise Value) |
578 M | 505 M | 537 M | 641 M | 714 M | 474 M | 800 M | 404 M | 323 M | 194 M | 290 M | 353 M | 433 M | 243 M | 4.53 M | -11.6 M | -15.4 M |
EBITDA per Share |
0.22 | 0.97 | -0.93 | 1.07 | 0.44 | 1.03 | 0.54 | 0.37 | 0.63 | 0.52 | 0.57 | 0.5 | 0.45 | 0.46 | 0.45 | 3.64 | - |
EV/EBITDA |
189.5 | 36.9 | -41.5 | 43.6 | 118.7 | 34.4 | 112.0 | 82.2 | 39.6 | 28.8 | 37.5 | 48.9 | 55.5 | 30.3 | 0.6 | -0.2 | - |
PEG |
0.63 | 7.29 | -2.6 | 4.02 | 53.07 | 2.86 | 94.35 | 336.84 | 19.8 | 27.96 | -7.26 | 0.3 | 0.18 | -0.37 | - | - | - |
P/B |
4.7 | 4.0 | 4.7 | 4.4 | 5.4 | 3.8 | 7.1 | 3.5 | 3.0 | 2.6 | 3.3 | 3.8 | 4.6 | 1.8 | - | - | - |
P/CF |
2234.2 | 45.7 | -29.4 | 40.1 | 50.4 | 58.2 | 22.5 | 28.2 | 12.8 | 21.1 | 18.5 | 22.3 | 24.9 | 10.9 | - | - | - |
ROE % |
-9.71 | -1.28 | -25.16 | 3.02 | 0.86 | 6.20 | 1.21 | -1.39 | 2.15 | 2.89 | 3.66 | 3.87 | 4.47 | 3.02 | -3.97 | 21.78 | - |
ROA % |
-6.46 | -0.83 | -17.22 | 2.18 | 0.67 | 4.75 | 0.80 | -1.14 | 1.73 | 2.69 | 3.45 | 3.56 | 4.07 | 2.71 | -3.62 | - | - |
ROCE % |
-4.75 | 4.29 | -20.39 | 4.78 | -0.95 | 4.63 | 0.55 | -0.50 | 2.66 | 4.19 | 4.99 | 4.51 | 5.01 | 3.31 | 2.65 | 33.36 | - |
Current Ratio |
3.0 | 2.8 | 3.2 | 3.6 | 4.5 | 4.3 | 3.0 | 5.5 | 5.1 | 14.4 | 17.1 | 12.6 | 11.2 | 9.1 | 10.7 | - | - |
DSO |
34.9 | 29.3 | 35.8 | 29.2 | 32.1 | 32.6 | 127.4 | 151.0 | 147.4 | 134.9 | 129.5 | 136.7 | 124.6 | 46.3 | - | - | - |
DIO |
165.8 | 194.9 | 166.7 | 135.2 | 124.7 | 114.0 | 98.2 | 113.4 | 109.7 | 43.9 | 43.6 | 52.9 | 173.4 | 182.2 | - | - | - |
DPO |
31.9 | 44.8 | 44.1 | 35.0 | 42.9 | 62.0 | 64.4 | 64.2 | 40.2 | 11.5 | 15.9 | 15.2 | 81.5 | 106.3 | - | - | - |
Operating Cycle |
200.8 | 224.2 | 202.5 | 164.4 | 156.8 | 146.6 | 225.7 | 264.4 | 257.1 | 178.8 | 173.2 | 189.6 | 298.0 | 228.4 | - | - | - |
Cash Conversion Cycle |
168.8 | 179.4 | 158.4 | 129.4 | 113.9 | 84.6 | 161.2 | 200.2 | 216.9 | 167.3 | 157.2 | 174.4 | 216.4 | 122.2 | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Surmodics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.37 | -0.36 | -0.26 | -0.26 | - | -0.53 | 0.02 | -0.06 | - | 0.52 | -0.55 | -0.56 | - | -0.41 | -0.29 | -0.2 | - | -0.24 | 0.59 | -0.02 | -0.22 | 0.18 | -0.02 | 0.01 | 0.27 | 0.11 | 0.01 | 0.1 | -0.13 | -0.2 | 0.1 | -0.12 | 0.03 | 0.05 | -0.12 | 0.17 | 0.2 | 0.31 | 0.17 | 0.2 | 0.1 | 0.3 | 0.19 | 0.27 | 0.17 | 0.26 | 0.27 | 0.26 | 0.26 | 0.22 | 0.26 | 0.29 | 0.26 | 0.22 | 0.29 | 0.29 | -1.07 | 0.22 | 0.15 |
EBITDA per Share |
-0.22 | -0.13 | -0.03 | -0.03 | - | -0.23 | 0.19 | 0.14 | - | 1.68 | -0.32 | -0.37 | - | -0.35 | -0.19 | -0.08 | - | -0.04 | 0.83 | 0.14 | 0.25 | 0.22 | 0.14 | 0.11 | 0.7 | 0.22 | 0.11 | 0.18 | 0.17 | -0.35 | 0.18 | 0.07 | 0.34 | 0.24 | 0.07 | 0.34 | 0.6 | 0.62 | 0.34 | 0.37 | 0.49 | 0.5 | 0.37 | 0.43 | 0.55 | 0.44 | 0.43 | 0.37 | 0.53 | 0.34 | 0.37 | 0.38 | 0.45 | 0.28 | 0.38 | 0.32 | 0.31 | 0.29 | 0.23 |
ROE % |
-16.04 | -17.65 | -12.73 | -10.10 | -6.84 | -0.30 | -1.45 | -8.96 | -8.32 | -12.83 | -22.43 | -16.95 | -9.64 | -3.87 | -1.68 | 7.30 | 9.15 | 1.13 | 5.31 | -0.82 | -0.49 | 4.66 | 4.00 | 4.33 | 5.36 | 0.85 | -2.70 | -1.67 | -4.23 | -2.26 | 0.75 | -1.81 | 1.74 | 3.80 | 6.83 | 10.39 | 11.03 | 10.10 | 10.69 | 11.27 | 12.91 | 13.81 | 13.18 | 14.10 | 13.76 | 15.31 | 15.01 | 15.22 | 15.44 | 15.39 | 15.35 | 16.01 | 14.68 | -2.45 | -3.00 | -5.59 | -13.25 | 2.75 | 1.94 |
ROA % |
-10.78 | -11.91 | -8.58 | -6.79 | -4.56 | -0.67 | -1.07 | -5.82 | -5.39 | -7.60 | -13.01 | -4.20 | 0.42 | 0.42 | -1.44 | 4.94 | 6.29 | 0.39 | 3.70 | -0.62 | -0.36 | 3.61 | 3.07 | 3.33 | 4.10 | 0.81 | -1.74 | -1.03 | -3.06 | -1.70 | 0.46 | -1.48 | 1.47 | 3.12 | 5.55 | 8.42 | 8.99 | 8.43 | 9.45 | 10.26 | 12.04 | 12.90 | 12.36 | 13.26 | 12.93 | 14.31 | 13.95 | 14.07 | 14.19 | 14.11 | 14.04 | 14.60 | 13.45 | -1.99 | -2.54 | -4.93 | -11.91 | 2.45 | 1.73 |
ROCE % |
-12.79 | -12.62 | -8.45 | -6.50 | -4.28 | 14.77 | 12.90 | 5.63 | 5.89 | 0.18 | -22.54 | -18.64 | -11.90 | -13.60 | -0.95 | 2.80 | 5.32 | 3.79 | 6.36 | -0.51 | -0.79 | 3.89 | 3.84 | 3.56 | 4.40 | -1.01 | -7.34 | -6.49 | -7.69 | -5.07 | 1.99 | 0.79 | 4.41 | 7.86 | 12.47 | 16.10 | 17.19 | 18.01 | 18.21 | 19.44 | 21.47 | 22.33 | 21.36 | 22.17 | 20.87 | 21.31 | 20.43 | 19.94 | 20.02 | 19.94 | 19.89 | 20.48 | 18.95 | 15.16 | 13.75 | 10.85 | 2.08 | 3.05 | 2.31 |
Current Ratio |
2.9 | 3.1 | 3.1 | 3.1 | 3.0 | 3.0 | 3.1 | 3.1 | 2.8 | 2.5 | 2.6 | 2.7 | 3.2 | - | 3.6 | 3.8 | 3.6 | 4.9 | 3.6 | 5.4 | 4.5 | 4.5 | 4.5 | 4.9 | 4.3 | 4.3 | 4.3 | 4.1 | 3.0 | 3.0 | 3.0 | 5.6 | 5.5 | 5.5 | 5.5 | 6.0 | 5.1 | 5.1 | 5.1 | 6.6 | 14.4 | 14.4 | 14.4 | 15.9 | 17.1 | 17.1 | 17.1 | 15.6 | 12.6 | 12.6 | 12.6 | 11.8 | 11.2 | 11.2 | 11.1 | 16.8 | 9.1 | 9.1 | 9.1 |
DSO |
38.2 | 39.2 | 38.3 | 39.4 | - | 38.7 | 36.0 | 35.5 | - | 20.8 | 37.2 | 37.5 | - | 20.3 | 33.3 | 34.1 | - | 34.0 | 22.5 | 32.2 | 31.1 | 26.1 | 31.4 | 33.6 | 26.6 | 33.7 | 37.7 | 38.2 | 35.2 | 36.4 | 37.3 | 37.3 | 32.8 | 37.0 | 36.8 | 34.4 | 34.5 | 31.4 | 31.8 | 35.9 | 39.3 | 42.9 | 32.9 | 29.5 | 28.3 | 29.7 | 33.1 | 34.3 | 35.1 | 34.9 | 32.5 | 31.2 | 32.4 | 32.4 | 32.4 | 30.1 | 28.8 | 30.8 | - |
DIO |
169.3 | 182.5 | 187.6 | 187.0 | - | 166.4 | 191.8 | 151.7 | - | 187.1 | 210.6 | 212.6 | - | 84.0 | 158.7 | 152.7 | - | 116.9 | 142.5 | 149.0 | 47.7 | 122.5 | 133.1 | 134.6 | 41.1 | 122.1 | 123.5 | 106.0 | 37.0 | 89.3 | 102.1 | 116.6 | 39.6 | 110.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
49.6 | 34.7 | 31.5 | 32.9 | - | 34.4 | 37.0 | 28.9 | - | 41.4 | 46.3 | 44.8 | - | 18.8 | 35.4 | 36.8 | - | 29.5 | 28.9 | 29.0 | 12.1 | 31.1 | 47.7 | 63.8 | 19.1 | 56.6 | 68.9 | 68.6 | 23.4 | 56.6 | 62.9 | 74.2 | 27.0 | 75.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 207.5 | 221.7 | 226.4 | - | 205.1 | 227.8 | 187.2 | - | 207.8 | 247.9 | 250.2 | - | 104.3 | 192.0 | 186.8 | - | 150.8 | 164.9 | 181.2 | 78.8 | 148.6 | 164.5 | 168.3 | 67.8 | 155.8 | 161.2 | 144.2 | 72.2 | 125.7 | 139.4 | 153.9 | 72.4 | 147.1 | 36.8 | 34.4 | 34.5 | 31.4 | 31.8 | 35.9 | 39.3 | 42.9 | 32.9 | 29.5 | 28.3 | 29.7 | 33.1 | 34.3 | 35.1 | 34.9 | 32.5 | 31.2 | 32.4 | 32.4 | 32.4 | 30.1 | 28.8 | 30.8 | - |
Cash Conversion Cycle |
- | 157.9 | 187.1 | 193.5 | - | 170.7 | 190.7 | 158.3 | - | 166.5 | 201.6 | 205.4 | - | 85.5 | 156.6 | 149.9 | - | 121.3 | 136.0 | 152.3 | 66.7 | 117.5 | 116.8 | 104.5 | 48.7 | 99.2 | 92.3 | 75.6 | 48.7 | 69.1 | 76.5 | 79.6 | 45.4 | 72.1 | 36.8 | 34.4 | 34.5 | 31.4 | 31.8 | 35.9 | 39.3 | 42.9 | 32.9 | 29.5 | 28.3 | 29.7 | 33.1 | 34.3 | 35.1 | 34.9 | 32.5 | 31.2 | 32.4 | 32.4 | 32.4 | 30.1 | 28.8 | 30.8 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Surmodics, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
Niderland
Germany
Israel
Britain
Canada
China
Australia
Schweiz
Irlanda
